155 related articles for article (PubMed ID: 21301088)
1. Crystallization and preliminary X-ray crystallographic studies of enoyl-acyl carrier protein reductase (FabI) from Psuedomonas aeruginosa.
Lee JH; Park AK; Chi YM; Moon JH; Lee KS
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Feb; 67(Pt 2):214-6. PubMed ID: 21301088
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis.
Hoang TT; Schweizer HP
J Bacteriol; 1999 Sep; 181(17):5489-97. PubMed ID: 10464225
[TBL] [Abstract][Full Text] [Related]
3. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
[TBL] [Abstract][Full Text] [Related]
4. Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase.
Zhu L; Lin J; Ma J; Cronan JE; Wang H
Antimicrob Agents Chemother; 2010 Feb; 54(2):689-98. PubMed ID: 19933806
[TBL] [Abstract][Full Text] [Related]
5. Crystallization and preliminary X-ray crystallographic analysis of enoyl-ACP reductase III (FabL) from Bacillus subtilis.
Kim KH; Park JK; Ha BH; Moon JH; Kim EE
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Mar; 63(Pt 3):246-8. PubMed ID: 17329825
[TBL] [Abstract][Full Text] [Related]
6. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
Massengo-Tiassé RP; Cronan JE
J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
[TBL] [Abstract][Full Text] [Related]
7. Crystallization and preliminary X-ray crystallographic analysis of enoyl-acyl carrier protein reductase from Helicobacter pylori.
Lee HH; Yun J; Moon J; Han BW; Lee BI; Lee JY; Suh SW
Acta Crystallogr D Biol Crystallogr; 2002 Jun; 58(Pt 6 Pt 2):1071-3. PubMed ID: 12037321
[TBL] [Abstract][Full Text] [Related]
8. The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.
Heath RJ; Su N; Murphy CK; Rock CO
J Biol Chem; 2000 Dec; 275(51):40128-33. PubMed ID: 11007778
[TBL] [Abstract][Full Text] [Related]
9. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.
Heath RJ; Rock CO
J Biol Chem; 1995 Nov; 270(44):26538-42. PubMed ID: 7592873
[TBL] [Abstract][Full Text] [Related]
10. Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei.
Lu H; Tonge PJ
Biochemistry; 2010 Feb; 49(6):1281-9. PubMed ID: 20055482
[TBL] [Abstract][Full Text] [Related]
11. Crystallization and preliminary X-ray analysis of enoyl-acyl carrier protein reductase (FabK) from Streptococcus pneumoniae.
Saito J; Yamada M; Watanabe T; Kitagawa H; Takeuchi Y
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Jun; 62(Pt 6):576-8. PubMed ID: 16754986
[TBL] [Abstract][Full Text] [Related]
12. The genome of a Bacteroidetes inhabitant of the human gut encodes a structurally distinct enoyl-acyl carrier protein reductase (FabI).
Radka CD; Frank MW; Yao J; Seetharaman J; Miller DJ; Rock CO
J Biol Chem; 2020 May; 295(22):7635-7652. PubMed ID: 32317282
[TBL] [Abstract][Full Text] [Related]
13. Characterization of protein-ligand binding interactions of enoyl-ACP reductase (FabI) by native MS reveals allosteric effects of coenzymes and the inhibitor triclosan.
Joyner PM; Tran DP; Zenaidee MA; Loo JA
Protein Sci; 2022 Mar; 31(3):568-579. PubMed ID: 34882866
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of triclosan inhibition of bacterial fatty acid synthesis.
Heath RJ; Rubin JR; Holland DR; Zhang E; Snow ME; Rock CO
J Biol Chem; 1999 Apr; 274(16):11110-4. PubMed ID: 10196195
[TBL] [Abstract][Full Text] [Related]
15. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
[TBL] [Abstract][Full Text] [Related]
16. Structure of the Francisella tularensis enoyl-acyl carrier protein reductase (FabI) in complex with NAD(+) and triclosan.
Mehboob S; Truong K; Santarsiero BD; Johnson ME
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1436-40. PubMed ID: 21045289
[TBL] [Abstract][Full Text] [Related]
17. High-resolution structures of Thermus thermophilus enoyl-acyl carrier protein reductase in the apo form, in complex with NAD+ and in complex with NAD+ and triclosan.
Otero JM; Noël AJ; Guardado-Calvo P; Llamas-Saiz AL; Wende W; Schierling B; Pingoud A; van Raaij MJ
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Oct; 68(Pt 10):1139-48. PubMed ID: 23027736
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogues.
Sivaraman S; Sullivan TJ; Johnson F; Novichenok P; Cui G; Simmerling C; Tonge PJ
J Med Chem; 2004 Jan; 47(3):509-18. PubMed ID: 14736233
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into the dimer-tetramer transition of FabI from Bacillus anthracis.
Kim HT; Kim S; Na BK; Chung J; Hwang E; Hwang KY
Biochem Biophys Res Commun; 2017 Nov; 493(1):28-33. PubMed ID: 28935372
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into Staphylococcus aureus enoyl-ACP reductase (FabI), in complex with NADP and triclosan.
Priyadarshi A; Kim EE; Hwang KY
Proteins; 2010 Feb; 78(2):480-6. PubMed ID: 19768684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
